Literature DB >> 12479823

Importance of innate immunity and collagen binding integrin alpha1beta1 in TNBS-induced colitis.

Stefano Fiorucci1, Andrea Mencarelli, Barbara Palazzetti, Andrew G Sprague, Eleonora Distrutti, Antonio Morelli, Tatiana I Novobrantseva, Giuseppe Cirino, Victor E Koteliansky, Antonin R de Fougerolles.   

Abstract

Inflammation occurs in the context of integrin-mediated adhesive interactions of cells with their extracellular matrix environment. We investigated the role of the collagen binding integrin alpha1beta1 in a model of colitis. alpha1beta1 was expressed on lamina propria T cells and monocytes during disease. Both alpha1 deficiency and anti-alpha1 mAb treatment (prophylactic and therapeutic) protected against colitis. In vivo alpha1beta1 blockade improved macroscopic and histologic scores, decreased inflammatory cytokine production, and profoundly affected the ability of lamina propria mononuclear cells to proliferate and produce IFN-gamma in vitro. Development and alpha1-mediated inhibition of colitis can be lymphocyte independent, suggesting that activated monocytes also represent a key alpha1beta1-expressing cell type involved in colitis. These results underscore the importance of innate immunity and, specifically, of leukocyte/matrix interactions in regulating local inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12479823     DOI: 10.1016/s1074-7613(02)00476-4

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  39 in total

1.  Structure of collagen receptor integrin α(1)I domain carrying the activating mutation E317A.

Authors:  Matti Lahti; Eva Bligt; Henri Niskanen; Vimal Parkash; Anna-Maria Brandt; Johanna Jokinen; Pekka Patrikainen; Jarmo Käpylä; Jyrki Heino; Tiina A Salminen
Journal:  J Biol Chem       Date:  2011-10-26       Impact factor: 5.157

2.  Cortistatin, an antiinflammatory peptide with therapeutic action in inflammatory bowel disease.

Authors:  Elena Gonzalez-Rey; Nieves Varela; Amir F Sheibanie; Alejo Chorny; Doina Ganea; Mario Delgado
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-07       Impact factor: 11.205

3.  Induction of murine TNBS colitis is strictly controlled by a modified method using continuous inhalation anesthesia with sevoflurane.

Authors:  Tomohiro Terai; Satoshi Osawa; Shinya Tani; Shinji Oishi; Yoshifumi Arai; Takanori Yamada; Mitsushige Sugimoto; Takahisa Furuta; Shigeru Kanaoka; Hiroaki Miyajima; Ken Sugimoto
Journal:  Dig Dis Sci       Date:  2014-01-23       Impact factor: 3.199

Review 4.  Pharmacological intervention studies using mouse models of the inflammatory bowel diseases: translating preclinical data into new drug therapies.

Authors:  Iurii Koboziev; Fridrik Karlsson; Songlin Zhang; Matthew B Grisham
Journal:  Inflamm Bowel Dis       Date:  2011-02-10       Impact factor: 5.325

5.  Effects of VLA-1 Blockade on Experimental Inflammation in Mice.

Authors:  Ryuichi Totsuka; Takaaki Kondo; Shigeki Matsubara; Midori Hirai; Yoichi Kurebayashi
Journal:  Kobe J Med Sci       Date:  2016-07-05

6.  Expression of the alpha1beta1 integrin, VLA-1, marks a distinct subset of human CD4+ memory T cells.

Authors:  Itamar Goldstein; Shomron Ben-Horin; Jianfeng Li; Ilan Bank; Hong Jiang; Leonard Chess
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

7.  Chemically induced mouse models of acute and chronic intestinal inflammation.

Authors:  Stefan Wirtz; Vanessa Popp; Markus Kindermann; Katharina Gerlach; Benno Weigmann; Stefan Fichtner-Feigl; Markus F Neurath
Journal:  Nat Protoc       Date:  2017-06-01       Impact factor: 13.491

8.  Epithelial EZH2 serves as an epigenetic determinant in experimental colitis by inhibiting TNFα-mediated inflammation and apoptosis.

Authors:  Yongfeng Liu; Junjie Peng; Tongyu Sun; Ni Li; Le Zhang; Jiale Ren; Huairui Yuan; Shan Kan; Qiang Pan; Xiang Li; Yufeng Ding; Min Jiang; Xiaoji Cong; Minjia Tan; Yushui Ma; Da Fu; Sanjun Cai; Yichuan Xiao; Xiaoming Wang; Jun Qin
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

9.  A novel murine model for chronic inflammatory alveolar bone loss.

Authors:  H S Oz; J L Ebersole
Journal:  J Periodontal Res       Date:  2009-07-08       Impact factor: 4.419

10.  Cyclin-dependent kinase inhibitors block leukocyte adhesion and migration.

Authors:  Li Liu; Barbara Schwartz; Yoshiaki Tsubota; Elaine Raines; Hiroaki Kiyokawa; Karyn Yonekawa; John M Harlan; Lynn M Schnapp
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.